Omkar Pharmachem Limited (BOM:532167)
India · Delayed Price · Currency is INR 11.65
-0.61 (-4.98%)
At close: Aug 21, 2026
Omkar Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | - | - | 5.4 | 5.4 | 5.4 | 5.4 |
Other Revenue | 4.2 | 4.65 | - | - | - | - |
| 4.2 | 4.65 | 5.4 | 5.4 | 5.4 | 5.4 | |
Revenue Growth | -22.22% | -13.89% | 0% | 0% | 0% | 100.00% |
Cost of Revenue | 2.11 | 2.09 | 1.61 | 1.61 | 1.39 | 1.75 |
Gross Profit | 2.09 | 2.56 | 3.79 | 3.8 | 4.01 | 3.65 |
Selling, General & Admin | - | - | 0.07 | 0.07 | 0.07 | 0.07 |
Other Operating Expenses | 0.95 | 0.96 | 0.83 | 0.9 | 0.84 | 0.9 |
Operating Expenses | 0.98 | 0.99 | 0.94 | 1.01 | 0.93 | 0.98 |
Operating Income | 1.12 | 1.58 | 2.85 | 2.78 | 3.08 | 2.67 |
Interest Expense | -0.02 | -0.02 | -0.17 | -0.29 | -0.47 | -0.56 |
Interest & Investment Income | - | - | 0.02 | 0.04 | 0.03 | - |
Other Non Operating Income (Expenses) | 0.07 | 0.07 | - | - | - | - |
EBT Excluding Unusual Items | 1.17 | 1.63 | 2.7 | 2.53 | 2.65 | 2.11 |
Pretax Income | 1.17 | 1.63 | 2.7 | 2.53 | 2.65 | 2.11 |
Income Tax Expense | 0.32 | 0.41 | 0.69 | 0.64 | 0.67 | 0.27 |
Net Income | 0.85 | 1.22 | 2.01 | 1.89 | 1.98 | 1.83 |
Net Income to Common | 0.85 | 1.22 | 2.01 | 1.89 | 1.98 | 1.83 |
Net Income Growth | -52.27% | -39.37% | 6.24% | -4.40% | 8.03% | -17.30% |
Shares Outstanding (Basic) | 10 | - | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | - | 10 | 10 | 10 | 10 |
Shares Change | 0.17% | - | - | - | - | - |
EPS (Basic) | 0.08 | - | 0.20 | 0.19 | 0.20 | 0.18 |
EPS (Diluted) | 0.08 | - | 0.20 | 0.19 | 0.20 | 0.18 |
EPS Growth | -52.35% | - | 6.24% | -4.40% | 8.97% | -18.02% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 2.28 | 2.4 | 2.86 | 2.76 | 1.96 |
Free Cash Flow Per Share | - | - | 0.24 | 0.28 | 0.27 | 0.19 |
Gross Margin | 49.83% | 55.14% | 70.24% | 70.28% | 74.28% | 67.57% |
Operating Margin | 26.60% | 33.87% | 52.76% | 51.56% | 57.07% | 49.41% |
Profit Margin | 20.29% | 26.19% | 37.20% | 35.02% | 36.63% | 33.91% |
Free Cash Flow Margin | - | 49.12% | 44.35% | 53.02% | 51.09% | 36.30% |
EBITDA | 1.15 | 1.61 | 2.9 | 2.83 | 3.11 | 2.69 |
EBITDA Margin | 27.30% | 34.58% | 53.63% | 52.43% | 57.57% | 49.76% |
D&A For EBITDA | 0.03 | 0.03 | 0.05 | 0.05 | 0.03 | 0.02 |
EBIT | 1.12 | 1.58 | 2.85 | 2.78 | 3.08 | 2.67 |
EBIT Margin | 26.60% | 33.87% | 52.76% | 51.56% | 57.07% | 49.41% |
Effective Tax Rate | 27.18% | 25.18% | 25.59% | 25.20% | 25.22% | 13.02% |
Revenue as Reported | 4.27 | 4.72 | 5.42 | 5.44 | 5.43 | 5.4 |
Advertising Expenses | - | - | 0.03 | 0.03 | 0.03 | 0.03 |